Chronic Lymphocytic Leukemia News
More Chronic Lymphocytic Leukemia Information
The available human studies do not support the role of Ginkgo biloba as a treatment for cancer, but the published studies were not placebo-controlled, making it difficult to draw conclusions from the data.
In vivo studies suggest that extracts of St John's wort may have apoptotic effects on cancer cells, but human studies have not been conducted to test this hypothesis.
Vitamin E supplementation appears to reduce the risk of chemotherapy-induced neurotoxicity and several radiation-induced toxicities, though one study found increased recurrence rates with its use.
Fish oil supplementation may improve chemotherapy-related outcomes, such as time to tumor progression, and may be protective against certain toxicities.
The data regarding sugar consumption and the increased risk of cancer are not consistent, making it difficult to draw definitive conclusions.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Arrival of CAR-T Immunotherapy Raise Hopes for Treatment and Anxieties About Costs
- St John's Wort and Cancer
- Osimertinib Granted Breakthrough Therapy Designation as First-line Treatment for EGFR-positive NSCLC
- Radiation Therapy Increases 5-year Rate of Cardiac Events in Small-cell Lung Cancer
- FDA Grants Priority Review to Afatinib for Uncommon EGFR-positive NSCLC
- NSCLC: Researchers Identify Socioeconomic Factors Linked to Overall Survival
- Savolitinib Plus Gefitinib May Be Effective in EGFR-Mutant, MET-amplified NSCLC
- Maintenance Pazopanib Provides PFS, not OS, Benefit in Small-cell Lung Cancer
- Pembrolizumab Plus Pemetrexed, Carboplatin Prolongs Survival in NSCLC
- Repeat T790M Testing Recommended for TKI-resistant Patients With NSCLC